Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Staying home for chemotherapy infusions and other treatments can save time and reduce anxiety surrounding contracting the virus.
Many 5-star nursing homes have infection-control lapses.
Speciality drug prices are so costly that many patients skip or ration them.
Those with Medicare or Medicaid fared worse than those with private insurance.
Medicare Advantage plans have lower premiums than Medigap plans but can be very expensive if you have a serious disease such as cancer.
Capitalizing on the growing popularity of genetic testing, scammers are persuading seniors to take two types of genetic screenings.
The program will pay 65% of the cost of providing the custom-made immunotherapy.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
This physician was disheartened by the health care system’s complexity and its all-too-frequent absence of caring and compassion.
Insurance companies can no longer implement harmful co-pay accumulator policies.
Advocates are demanding that the Trump administration remove its restrictions and expand coverage for the cancer treatment.
Specialty-tier drugs for multiple sclerosis, cancer and other conditions account for more than 20 percent of total spending in Part D plans.
Experts are questioning whether the groups’ financial ties could push them to put drugmakers’ interests ahead of the people they represent...
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.